Steve Bryson PhD, —

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.

Articles by Steve Bryson

THROMBOTIC THROMBOCYTOPENIC PURPURA

August 13, 2025 News by Steve Bryson PhD

Platelet transfusion tied to much higher risk of death in TTP: Study

Platelet transfusions more than double the risk of death among people with thrombotic thrombocytopenic purpura (TTP), according to a review of published studies.

IMMUNE THROMBOCYTOPENIA

August 11, 2025 News by Steve Bryson PhD

AI predicts how kids with ITP will respond to rituximab infusion

Artificial intelligence (AI) can accurately predict a response to the second-line therapy rituximab in children and adolescents with immune thrombocytopenia (ITP), according to a…

Steve Bryson PhD, —

Articles by Steve Bryson

Platelet transfusion tied to much higher risk of death in TTP: Study

AI predicts how kids with ITP will respond to rituximab infusion

Recent Posts